◀ Back to IL13

IL13 — IL2RA

Text-mined interactions from Literome

Smith et al., Allergy 2004 (Asthma) : CD4 ( + ) CD25 ( + ) T cells suppressed both proliferation and IL-13 production by CD4 ( + ) CD25 ( - ) T cells before and after therapy but peptide therapy was not associated with any change in suppressive activity of these cells
Benghiat et al., Transplantation 2005 : Finally, natural CD25 ( + ) Treg cells inhibited the production of interleukin (IL)-2, interferon-gamma, IL-5, and IL-13 in mixed lymphocyte culture in a dose dependent manner
Leech et al., J Immunol 2007 (Asthma...) : Most convincingly, transfer of CD4 ( + ) CD25 ( + ) Foxp3 ( + ) T cells from Ag naive mice ( natural Tregs ) abolished AAI, decreased dMLN IL-5 and IL-13 secretion, increased dMLN IL-10 secretion, abolished IgE, and decreased IgG1 Abs. Blocking IL-10 receptor function in vivo did not block the anti-inflammatory function of transferred natural Tregs but did restore dMLN IL-5 and IL-13 secretion
Zhao et al., Leukemia 2008 (Hypersensitivity, Delayed) : sorafenib also caused G ( 0 ) /G ( 1 ) phase arrest, inhibition of CD25 and CD69 expression, interleukin-2 production and LCK phosphorylation in the T cells ; all of these effects exhibited dose and time dependence
Chaput et al., Gut 2009 (Adenocarcinoma...) : Finally, interleukin 6 and TGF beta 1 synergistically induced the generation of CD8 ( + ) CD25 ( + ) Foxp3 ( + ) T cells ex vivo
Shirakawa et al., Mol Cell Biol 1989 : Identical results were obtained with the human natural killer-like cell line YT, which can be induced to express the interleukin-2 receptor alpha subunit in response to interleukin-1 , cyclic AMP, or phorbol 12-myristate 13-acetate
Burlinson et al., Immunol Lett 1995 : IL-4 is the only cytokine apparently capable of promoting CD25 expression in human high-density quiescent tonsillar B cells ; neither IL-10 nor IL-13 could induce CD25 expression